Oncolytics Biotech Inc(ONCY),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

ONCY Oncolytics Biotech Inc

Trading 10-29 14:25:20 EDT

0.4337

-0.0079

-1.79%

High0.4500	Low0.4337	Vol459.68K
Open0.4400	D1 Closing0.4416	Amplitude3.69%
Mkt Cap56.81M	Tradable Cap55.32M	Total Shares131.00M
T/O203.14K	T/O Rate0.36%	Tradable Shares127.54M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"ONCY","market":"US","secType":"STK","nameCN":"Oncolytics Biotech Inc","latestPrice":0.4337,"timestamp":1793297996511,"preClose":0.4416,"halted":0,"volume":459682,"delay":0,"changeRate":-0.01788949275362323,"floatShares":127542809,"shares":131000000,"eps":-0.340636,"marketStatus":"Trading","change":-0.0079,"latestTime":"10-29 14:25:20 EDT","open":0.44,"high":0.45,"low":0.4337,"amount":203143.48307714,"amplitude":0.036911,"askPrice":0.4351,"askSize":90,"bidPrice":0.4337,"bidSize":2709,"shortable":3,"etf":0,"ttmEps":-0.340636,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1793304000000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":1002254400000,"exchange":"NASDAQ","adjPreClose":0.4416,"preHourTrading":{"tag":"盘前","latestPrice":0.4441,"preClose":0.4416,"latestTime":"09:27 EDT","volume":2322,"amount":1024.9217442,"timestamp":1793280479197,"change":0.0025,"changeRate":0.005661,"amplitude":0.024683},"postHourTrading":{"tag":"盘后","latestPrice":0.4441,"preClose":0.4416,"latestTime":"19:58 EDT","volume":2733,"amount":1196.8969,"timestamp":1793231928365,"change":0.0025,"changeRate":0.005661,"amplitude":0.059556},"volumeRatio":0.66633},"requestUrl":"/m/hq/s/ONCY","defaultTab":"news","newsList":[{"id":"2678106830","title":"Oncolytics Says Pelareorep Shows Durable Survival Benefit in Anal Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2678106830","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2678106830?lang=en_us&edition=fundamental","pubTime":"2026-10-27 22:33","pubTimestamp":1793111596,"startTime":"0","endTime":"0","summary":"BRIEF-Oncolytics Says Pelareorep Shows Durable Survival Benefit in Anal CancerOct 27 (Reuters)-Oncolytics Biotech IncONCY.O:ONCOLYTICS BIOTECH REPORTS STRONG DURABILITY AND SURVIVAL DATA IN ANAL CANCE","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261027:nFWN46D1PI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ONCY","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678103987","title":"Oncolytics reports updated data from Cohort 4 of Phase 1/2 GOBLET studt","url":"https://stock-news.laohu8.com/highlight/detail?id=2678103987","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2678103987?lang=en_us&edition=fundamental","pubTime":"2026-10-27 21:35","pubTimestamp":1793108150,"startTime":"0","endTime":"0","summary":"Oncolytics (ONCY) Biotech announced updated data from Cohort 4 of its Phase 1/2 GOBLET study evaluating pelareorep in combination with atezolizumab...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/oncolytics-reports-updated-data-from-cohort-4-of-phase-1-2-goblet-studt-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/oncolytics-reports-updated-data-from-cohort-4-of-phase-1-2-goblet-studt-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XBI","ONCY","BK4585","BK4588","BK4139","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678038101","title":"Oncolytics Biotech® Reports Strong Durability and Survival Data in Anal Cancer, Positioning Pelareorep as Potential Backbone Immunotherapy Across Hpv-Driven Cancers","url":"https://stock-news.laohu8.com/highlight/detail?id=2678038101","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2678038101?lang=en_us&edition=fundamental","pubTime":"2026-10-27 21:32","pubTimestamp":1793107977,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261027:nFWN46D1PI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ONCY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678074108","title":"Oncolytics Reports About 15-Month Median Response Duration for Pelareorep Combination in Anal Cancer Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2678074108","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2678074108?lang=en_us&edition=fundamental","pubTime":"2026-10-27 21:31","pubTimestamp":1793107915,"startTime":"0","endTime":"0","summary":"Oncolytics Reports About 15-Month Median Response Duration for Pelareorep Combination in Anal Cancer TrialOncolytics Biotech today reported updated GOBLET trial results for pelareorep with atezolizuma","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261027:nNDL6lSQZZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4112","BK4585","NDAQ","IE00BN0W2T93.GBP","ONCY","SG9999014039.USD","LU0314104364.USD","BK4588","IE00BQXX3D17.EUR","LU2210149790.SGD","IE00BKPKM429.USD","IE00BN0W2W23.USD","SG9999014013.SGD","IE00B3QW5Z07.USD","IE00BQXX3C00.GBP","SG9999014021.USD","SG9999014005.SGD","BK4139","IE00BGHQF748.EUR","IE00B64PRP62.GBP","BCDF","LU2210150020.SGD","LU2095319765.USD","IE00BQXX3F31.USD","IE00BN0W2V16.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676699176","title":"Oncolytics Biotech Presents Phase 2 Pelareorep Colorectal Cancer Trial Design at ESMO","url":"https://stock-news.laohu8.com/highlight/detail?id=2676699176","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2676699176?lang=en_us&edition=fundamental","pubTime":"2026-10-20 21:35","pubTimestamp":1792503327,"startTime":"0","endTime":"0","summary":"Oncolytics Biotech Presents Phase 2 Pelareorep Colorectal Cancer Trial Design at ESMOOncolytics Biotech will present its Phase 2 REO 033 trial-in-progress abstract at ESMO 2026, rather than new treatm","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261020:nNDL5WNpLP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BN0W2W23.USD","SG9999014005.SGD","BK4139","IE00BQXX3D17.EUR","ONCY","LU2210149790.SGD","IE00B64PRP62.GBP","IE00B3QW5Z07.USD","BCDF","LU2210150020.SGD","BK4585","IE00BQXX3C00.GBP","IE00BKPKM429.USD","SG9999014039.USD","SG9999014013.SGD","IE00BN0W2T93.GBP","LU0314104364.USD","LU2095319765.USD","BK4112","IE00BGHQF748.EUR","NDAQ","SG9999014021.USD","IE00BN0W2V16.EUR","BK4588","IE00BQXX3F31.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675334711","title":"Oncolytics Biotech Expects Final Goblet Cohort 4 Results in Q4 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2675334711","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675334711?lang=en_us&edition=fundamental","pubTime":"2026-10-14 21:30","pubTimestamp":1791984635,"startTime":"0","endTime":"0","summary":"Oncolytics Biotech Expects Final GOBLET Cohort 4 Results in Q4 2026Oncolytics Biotech expects final GOBLET Cohort 4 results in fourth-quarter 2026; initial Cohort 5 results are expected in first-half ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261014:nNDL26Ckl3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0314104364.USD","LU2210150020.SGD","SG9999014013.SGD","NDAQ","BK4112","ONCY","LU2095319765.USD","IE00B3QW5Z07.USD","IE00BQXX3C00.GBP","IE00BKPKM429.USD","IE00BN0W2W23.USD","SG9999014005.SGD","BK4588","SG9999014039.USD","IE00B64PRP62.GBP","IE00BN0W2T93.GBP","IE00BQXX3D17.EUR","SG9999014021.USD","IE00BGHQF748.EUR","BCDF","IE00BN0W2V16.EUR","LU2210149790.SGD","BK4139","IE00BQXX3F31.USD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675347162","title":"Oncolytics Biotech - Final Cohort 4 Results Expected in Q4 2026; Initial Cohort 5 Results in H1 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2675347162","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675347162?lang=en_us&edition=fundamental","pubTime":"2026-10-14 21:30","pubTimestamp":1791984600,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261014:nTUA3FKZHG:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ONCY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675193347","title":"Oncolytics Biotech® Provides Update on Goblet Study Clinical Data and Final Pancan Grant Payment","url":"https://stock-news.laohu8.com/highlight/detail?id=2675193347","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675193347?lang=en_us&edition=fundamental","pubTime":"2026-10-14 21:30","pubTimestamp":1791984600,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261014:nTUA3FKZHG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ONCY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675138899","title":"Oncolytics Biotech Details on Intellectual Property Strategy","url":"https://stock-news.laohu8.com/highlight/detail?id=2675138899","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675138899?lang=en_us&edition=fundamental","pubTime":"2026-10-13 05:42","pubTimestamp":1791841376,"startTime":"0","endTime":"0","summary":"Oncolytics Biotech (ONCY) late Monday updated on its intellectual property strategy for investigational immunotherapy pelareorep.Oncolytics said a new method of use patent covering pelareorep as a can","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CLR.SI","GLS.SI","ONCY","BK4139","USRD","BK4588","CFA.SI","BK4581","SRU.SI","XBI","SRT.SI","JJJ.SI","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675331800","title":"Oncolytics provides intellectual property portfolio update","url":"https://stock-news.laohu8.com/highlight/detail?id=2675331800","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675331800?lang=en_us&edition=fundamental","pubTime":"2026-10-13 04:15","pubTimestamp":1791836109,"startTime":"0","endTime":"0","summary":"Oncolytics (ONCY) provided an update on its intellectual property strategy, outlining progress on new method of use patents and plans to expand its...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/oncolytics-provides-intellectual-property-portfolio-update-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/oncolytics-provides-intellectual-property-portfolio-update-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","ONCY","NXTI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675807764","title":"Oncolytics Biotech Says New Pelareorep Cancer Immunotherapy Method-of-Use Patent Issues in Several Countries","url":"https://stock-news.laohu8.com/highlight/detail?id=2675807764","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675807764?lang=en_us&edition=fundamental","pubTime":"2026-10-13 04:06","pubTimestamp":1791835596,"startTime":"0","endTime":"0","summary":"Oncolytics Biotech says new pelareorep cancer immunotherapy method-of-use patent issues in several countriesOncolytics disclosed new method-of-use patents issued in several countries covering pelareor","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261012:nNDL37dNj9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210149790.SGD","IE00BQXX3C00.GBP","BK4139","IE00BN0W2W23.USD","BK4112","BCDF","IE00B3QW5Z07.USD","NDAQ","IE00BN0W2V16.EUR","SG9999014005.SGD","LU2210150020.SGD","LU0314104364.USD","SG9999014013.SGD","ONCY","IE00BGHQF748.EUR","BK4588","LU2095319765.USD","IE00BN0W2T93.GBP","SG9999014039.USD","IE00BQXX3D17.EUR","IE00BKPKM429.USD","IE00B64PRP62.GBP","IE00BQXX3F31.USD","BK4585","SG9999014021.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675807249","title":"Oncolytics Biotech® Secures Patent Protection to Late 2040S and Provides Intellectual Property Portfolio Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2675807249","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675807249?lang=en_us&edition=fundamental","pubTime":"2026-10-13 04:05","pubTimestamp":1791835501,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261012:nTUABRBTQY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ONCY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675807246","title":"Oncolytics Biotech - Company Expects to Add New Composition of Matter Patent for Next Generation Pelareorep","url":"https://stock-news.laohu8.com/highlight/detail?id=2675807246","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675807246?lang=en_us&edition=fundamental","pubTime":"2026-10-13 04:05","pubTimestamp":1791835501,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261012:nTUABRBTQY:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ONCY","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675807220","title":"Oncolytics Biotech - New Method of Use Patent for Pelareorep Issued in Several Countries; U.S. Issuance Expected Soon","url":"https://stock-news.laohu8.com/highlight/detail?id=2675807220","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675807220?lang=en_us&edition=fundamental","pubTime":"2026-10-13 04:05","pubTimestamp":1791835501,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261012:nTUABRBTQY:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ONCY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675780724","title":"Oncolytics Biotech - Three Patent Applications Pending; One to be Converted to Track One This Quarter","url":"https://stock-news.laohu8.com/highlight/detail?id=2675780724","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675780724?lang=en_us&edition=fundamental","pubTime":"2026-10-13 04:05","pubTimestamp":1791835501,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261012:nTUABRBTQY:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ONCY","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671210185","title":"Oncolytics announces publication of data on pelareorep in liver cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2671210185","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671210185?lang=en_us&edition=fundamental","pubTime":"2026-09-29 21:45","pubTimestamp":1790689517,"startTime":"0","endTime":"0","summary":"Oncolytics (ONCY) Biotech announced data published in the Proceedings of the National Academy of Sciences show pelareorep’s ability to change an im...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/oncolytics-announces-publication-of-data-on-pelareorep-in-liver-cancer-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/oncolytics-announces-publication-of-data-on-pelareorep-in-liver-cancer-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4585","BK4588","BK4581","XBI","ONCY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671217904","title":"Oncolytics Biotech Says Study Shows Pelareorep Triggers Immune Activation in Liver Cancer, Boosting Immunotherapy Sensitivity","url":"https://stock-news.laohu8.com/highlight/detail?id=2671217904","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671217904?lang=en_us&edition=fundamental","pubTime":"2026-09-29 21:30","pubTimestamp":1790688651,"startTime":"0","endTime":"0","summary":"Oncolytics Biotech says study shows pelareorep triggers immune activation in liver cancer, boosting immunotherapy sensitivityOncolytics Biotech flagged a peer-reviewed publication dated Sept. 28, 2026","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nNDL9sn2Wk:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4112","NDAQ","IE00BQXX3D17.EUR","IE00B3QW5Z07.USD","IE00BGHQF748.EUR","IE00BN0W2T93.GBP","IE00B64PRP62.GBP","IE00BN0W2W23.USD","ONCY","SG9999014039.USD","IE00BQXX3C00.GBP","IE00BQXX3F31.USD","LU2210150020.SGD","SG9999014005.SGD","SG9999014013.SGD","BK4588","IE00BN0W2V16.EUR","LU0314104364.USD","BK4585","IE00BKPKM429.USD","SG9999014021.USD","LU2210149790.SGD","BCDF","LU2095319765.USD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670258185","title":"Oncolytics reports accelerating enrollment in REO 033 study","url":"https://stock-news.laohu8.com/highlight/detail?id=2670258185","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670258185?lang=en_us&edition=fundamental","pubTime":"2026-09-28 21:35","pubTimestamp":1790602542,"startTime":"0","endTime":"0","summary":"Oncolytics (ONCY) Biotech announced continued clinical and operational progress in REO 033, its randomized study evaluating pelareorep in second-li...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/oncolytics-reports-accelerating-enrollment-in-reo-033-study-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/oncolytics-reports-accelerating-enrollment-in-reo-033-study-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4581","XBI","BK4585","BK4588","ONCY","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670625833","title":"Oncolytics Biotech - Expects Interim Part a Clinical Update by Year-End 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2670625833","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670625833?lang=en_us&edition=fundamental","pubTime":"2026-09-28 21:30","pubTimestamp":1790602200,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260928:nTUACBFVNJ:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ONCY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670258332","title":"Oncolytics Biotech® Reports Accelerating Enrollment in Randomized Reo 033 Ras-Mutant, Mss Colorectal Cancer Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2670258332","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670258332?lang=en_us&edition=fundamental","pubTime":"2026-09-28 21:30","pubTimestamp":1790602200,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260928:nTUACBFVNJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ONCY","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.oncolyticsbiotech.com","stockEarnings":[{"period":"1week","weight":-0.1365},{"period":"1month","weight":-0.3339},{"period":"3month","weight":-0.4135},{"period":"6month","weight":-0.4925},{"period":"1year","weight":-0.638},{"period":"ytd","weight":-0.4947}],"compareEarnings":[{"period":"1week","weight":-0.001},{"period":"1month","weight":0.0088},{"period":"3month","weight":0.0413},{"period":"6month","weight":0.0717},{"period":"1year","weight":0.1241},{"period":"ytd","weight":0.1326}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Oncolytics Biotech Inc., a development-stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancer. The company is developing pelareorep, an intravenously delivered immunotherapeutic agent, which is in phase 3 clinical trial for the treatment of hormone receptor-positive / human epidermal growth factor 2-negative metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma. Oncolytics Biotech Inc. has a co-development agreement with Merck KGaA and Pfizer Inc. to co-develop pelareorep in combination with paclitaxel and Bavencio, a human anti-PD-L1 antibody for the treatment of hormone receptor-positive/human epidermal growth factor 2-negative metastatic breast cancer. The company was incorporated in 1998 and is headquartered in Calgary, Canada.","yearOnYearQuotes":[{"month":1,"riseRate":0.625,"avgChangeRate":0.001975},{"month":2,"riseRate":0.25,"avgChangeRate":-0.025046},{"month":3,"riseRate":0.125,"avgChangeRate":-0.123611},{"month":4,"riseRate":0.75,"avgChangeRate":0.024604},{"month":5,"riseRate":0.375,"avgChangeRate":0.014597},{"month":6,"riseRate":0.25,"avgChangeRate":0.155922},{"month":7,"riseRate":0.444444,"avgChangeRate":-0.014421},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.069615},{"month":9,"riseRate":0.111111,"avgChangeRate":-0.044849},{"month":10,"riseRate":0.444444,"avgChangeRate":0.090776},{"month":11,"riseRate":0.25,"avgChangeRate":0.020161},{"month":12,"riseRate":0.125,"avgChangeRate":0.270533}],"exchange":"NASDAQ","name":"Oncolytics Biotech Inc","nameEN":"Oncolytics Biotech Inc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.52.0","shortVersion":"4.52.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Oncolytics Biotech Inc(ONCY),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Oncolytics Biotech Inc(ONCY) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Oncolytics Biotech Inc,ONCY,Oncolytics Biotech Inc股票,Oncolytics Biotech Inc股票老虎,Oncolytics Biotech Inc股票老虎国际,Oncolytics Biotech Inc行情,Oncolytics Biotech Inc股票行情,Oncolytics Biotech Inc股价,Oncolytics Biotech Inc股市,Oncolytics Biotech Inc股票价格,Oncolytics Biotech Inc股票交易,Oncolytics Biotech Inc股票购买,Oncolytics Biotech Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Oncolytics Biotech Inc(ONCY),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Oncolytics Biotech Inc(ONCY) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}